Moxifloxacin-Induced Sweet Syndrome in a 85-year-old Female with Prosthetic Joint Infection
Abstract
An 85-year old female with history of recurrent Streptococcus Agalactiae bacteremia with cardiovascular implantable electronic device lead vegetations and bilateral hip arthroplasties presented to the Emergency Department with concern for right hip cellulitis. Culture of joint aspirate was performed and grew Strep Agalactiae. The patient declined orthopedic surgical intervention and was started on intravenous antibiotics then transitioned to daily moxifloxacin 400mg by mouth. After several weeks of moxifloxacin therapy, the patient developed low grade fevers, malaise, and painful cutaneous lesions on both hands (Figure 1 and 2). Laboratory evaluation was significant for an elevated ESR (86mm/hr), CRP(22mg/dL) and a normal WBC count. She was referred to dermatology for evaluation and a biopsy of a representative lesion was performed with a clinical differential diagnosis of Sweet syndrome, Janeway lesions, and erythema muliforme.
Document Details
- Document Type
- Technical Report
- Publication Date
- Apr 25, 2019
- Accession Number
- AD1081752
Entities
People
- Brittany Lenz
- Jacob G. Dodd
- Jared Roberts
- Justin Bandino
Organizations
- 59th Medical Wing